AIFM1 is a prognostic biomarker for uterine carcinosarcoma and is associated with immune cell infiltration
Lijuan Wang,
Hua Xu,
Dianbo Xu
Affiliations
Lijuan Wang
Department of Gynecology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China
Hua Xu
Department of Gynecology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China
Dianbo Xu
Corresponding author. Department of Gynecology, the Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China; Department of Gynecology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China
